High-resolution characterization of a hepatocellular carcinoma genome

Nature Genetics

Volumn 43, Issue 5, 2011, Pages 464-471

  Totoki, Yasushi ^a   Tatsuno, Kenji ^b   Yamamoto, Shogo ^b   Arai, Yasuhito ^a   Hosoda, Fumie ^a   Ishikawa, Shumpei ^c   Tsutsumi, Shuichi ^b   Sonoda, Kohtaro ^b   Totsuka, Hirohiko ^a   Shirakihara, Takuya ^a   Sakamoto, Hiromi ^a   Wang, Linghua ^b   Ojima, Hidenori ^a   Shimada, Kazuaki ^d   Kosuge, Tomoo ^d   Okusaka, Takuji ^d   Kato, Kazuto ^e   Kusuda, Jun ^f   Yoshida, Teruhiko ^a   Aburatani, Hiroyuki ^b   Shibata, Tatsuhiro ^a   more..

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA REPAIR; FUSION GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TUMOR GENE;

HEPATITIS C VIRUS;

EID: 85027927831     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.804     Document Type: Article

References (26)

1. El-Serag, H.B. & Rudolph, K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576 (2007). (Pubitemid 46890874)
2. Bentley, D.R. et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456, 53-59 (2008).
3. Huang, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc. 4, 44-57 (2009).
4. Ng, S.B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272-276 (2009).
5. Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 27, 182-189 (2009).
6. Pleasance, E.D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010).
7. Xiang, Z. et al. Identifcation of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood 111, 4809-4812 (2008).
8. Pagan, J.K. et al. A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP. J. Biol. Chem. 282, 15248-15257 (2002).
9. Miyazaki, Y., Sun, X., Uchida, H., Zhang, J. & Nimer, S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 13, 1721-1729 (1996). (Pubitemid 26377504)
10. Suico, M.A. et al. Functional dissection of the ETS transcription factor MEF. Biochim. Biophys. Acta 1577, 113-120 (2002). (Pubitemid 34876610)
11. Mardis, E.R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009).
12. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
13. Shah, S.P. et al. Mutation evolution in a lobular breast tumour profled at single nucleotide resolution. Nature 461, 809-813 (2009).
14. Parsons, D.W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008).
15. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008).
16. Wood, L.D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007). (Pubitemid 350134889)
17. Pleasance, E.D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184-190 (2010).
18. Lee, W. et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465, 473-477 (2010).
19. Greenman, C et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007). (Pubitemid 46398669)
20. Machida, K. et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl. Acad. Sci. USA 101, 4262-4267 (2004).
21. Kim, M.Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326 (2009).
22. Guertin, D.A. & Sabatini, D.M. Defning the role of mTOR in cancer. Cancer Cell 12, 9-22 (2007).
23. Yilmaz, O.H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475-482 (2006). (Pubitemid 44050144)
24. Meric-Bernstam, F. & Gonzalez-Angulo, A.M. Targeting the mTOR signaling network for cancer therapy. J. Clin. Oncol. 27, 2278-2287 (2009).
25. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 25, 1754-1760 (2009).
26. Li, H. et al. The Sequence alignment/map (SAM) format and SAMtools. Bioinformatics 25, 2078-2079 (2009).